Use of prior authorization and step therapy prohibition for drugs used in the treatment of opioid use disorder under medical assistance

This bill prohibits prior authorization and step therapy requirements for FDA-approved medications treating opioid use disorder under Minnesota's medical assistance programs (like Medicaid). It directly affects patients seeking opioid treatment and healthcare providers who prescribe these medications, removing bureaucratic barriers to access. The key provision amends Minnesota Statutes to explicitly state that prior authorization or step therapy cannot be used for any class of drugs approved by the FDA for opioid use disorder treatment. This creates a clear policy change ensuring these critical medications are available without additional administrative hurdles.